Alternatively, if a tumor model of interest has a high level of TILs or PD-L1 expression that indicates a high responsiveness to a corresponding ICI agent, the ICI could be applied prior to chemotherapy (Figure 5C). The gene discussed is CD274; the disease is neoplasm.